Showing results (191-200 of 200) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Plos One|February 26, 2013
Feedback-based, system-level properties of vertebrate-microbial interactionsAriel L Rivas, Mark D Jankowski, Renata Piccinini, et al.Journal of Neurointerventional Surgery|August 1, 2023
MR microscopy to assess clot composition following mechanical thrombectomy predicts recanalization and clinical outcomeKianush Karimian-Jazi, Dominik F Vollherbst, Daniel Schwarz, et al.Journal of Medicinal Chemistry|June 28, 2022
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead <b>MSC-4106</b>Timo Heinrich, Carl Peterson, Richard Schneider, et al.Journal of Medicinal Chemistry|November 10, 2025
Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective InhibitorsTimo Heinrich, Alessia Gambardella, Daniel Schwarz, et al.Journal of Medicinal Chemistry|December 20, 2024
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686Timo Heinrich, Daniel Schwarz, Carl Petersson, et al.Journal of Medicinal Chemistry|January 23, 2016
Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19Aurélie Mallinger, Kai Schiemann, Christian Rink, et al.Nature Chemical Biology|October 27, 2015
A selective chemical probe for exploring the role of CDK8 and CDK19 in human diseaseTrevor Dale, Paul A Clarke, Christina Esdar, et al.Journal of Medicinal Chemistry|December 8, 2025
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1Sam E Mann, Owen A Davis, Jörg Bomke, et al.NPJ Digital Medicine|August 1, 2025
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapiesUlrike Weirauch, Markus Kreuz, Colin Birkenbihl, et al.Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.Pageof 20